Bend Research

Trending Articles

  1. Knowledge and adaptability drive successful pharmaceutical outsourcing partnerships Third-party contract manufacturers and packers play an increasingly prominent role in the pharmaceutical sector, helping companies to both navigate the complexities of the...
  2. PROFINET enables the seamless integration of Watson-Marlow pumps into Kühner single-use bioreactors A PROFINET interface has enabled the seamless integration of Watson-Marlow 630PnN/R and 730PnN/R pumps into the Siemens environment of Adolf Kühner AG’s SB2500-Z orbital...
  3. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  4. Formulated Solutions puts the spotlight on consumer healthcare products at CPHI Located at stand 18F6, Formulated Solutions will be showcasing its game-changing development and manufacturing capabilities for consumer health, Rx therapeutics and medical...
  5. At Pack Expo 2024, Antares Vision Group to debut versatile, high-speed serialization station for pharma bottles of various shapes and sizes Antares Vision Group will also introduce a serialization module for flat cartons and demonstrate a high-speed automated visual inspection unit for liquid-filled vials

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Manufacturing

Capsugel adds new commercial-scale spray-dried dispersion capacity at Bend Research

Completes first part of planned US$20m expansion at the plant in Oregon, US
Manufacturing

Bend Research to invest US$20m to expand spray-dried dispersion manufacturing

Will be completed and validated by June 2015
Drug Delivery

Capsugel to buy Bend Research

Adding to its dosage forms business
Ingredients

BASF and Bend Research to develop solubility enhancing excipients

Initially focusing on vinylpyrrolidone-based copolymers
Manufacturing

Dow Chemical and Cambrex collaborate to manufacture drug-solubility solution

Builds on the solubilisation partnership between Dow and Bend Research announced in October 2012
You need to be a subscriber to read this article.
Click here to find out more.
Ingredients

Problem-solving ingredients for complex drugs

Around 40% of new chemical entities fall into class II – low solubility drugs, making them difficult to formulate. Improving the bioavailability of these compounds is a major challenge but the technologies involved could help to extend the lifecycle of many medicines. Manufacturers are also looking to improve palatability and diversify drug delivery routes to increase patient compliance.
Manufacturing

Catalent and Bend to offer oral drug formulation services

Aiming to provide a more efficient path to market
Subscribe now